The PRELIEVE trial:Final 1-year outcomes of the prospective atrial flow regulator study

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Christina Paitazoglou

University Heart Center, Luebeck (Germany)

7 More presentations in this session

Presentation thumbnail

Transcatheter endomyocardial alginate-hydrogel injection for treatment of heart failure

Doctor B. Wang (Galway, IE)

Abstract Slides

Presentation thumbnail

Interventional rhythm control is associated with an improved long-term prognosis of patients with atrial fibrillation undergoing transcatheter edge-to-edge mitral valve repair

Doctor C. Waechter (Muenster, DE)

Abstract Slides Video

Presentation thumbnail

Tricuspid regurgitation and heart failure: the faith of treated vs untreated cohort in the percutaneous era

Doctor E. Zancanaro (Mainz, DE)

Abstract Slides Video

Presentation thumbnail

Impact of sacubitril valsartan initiation in patients with HFrEF and severe mitral regurgitation referred for percutaneous mitral repair

Mrs M. Rivadeneira Ruiz (Madrid, ES)

Abstract Slides Video

Presentation thumbnail

A proactive care pathway that improves medical therapy for patients with heart failure with reduced ejection fraction and implantable cardiac devices

Doctor H. Williams (Bristol, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Complex and novel interventions for heart failure

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

You may be interested in

Congress Session

Navigating through heart failure device therapies

Congress Session

Multidisciplinary approach in heart failure clinic

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources